Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Seattle Genetics Inc (NASDAQ:SGEN)

62.73
Delayed Data
As of Feb 24
 -0.34 / -0.54%
Today’s Change
28.32
Today|||52-Week Range
75.36
+18.87%
Year-to-Date
3 Biotech Long Shots: Boom Or Bust?
Feb 24 / MotleyFool.com - Paid Partner Content
Biotech Stock Roundup: Regeneron's Praluent to Remain on Market for Now, GILD Present...
Feb 15 / Zacks.com - Paid Partner Content
Bear of the Day: Seattle Genetics (SGEN)
Feb 24 / Zacks.com - Paid Partner Content
Seattle Genetics Earnings: Waiting on ECHELON
Feb 13 / MotleyFool.com - Paid Partner Content
7 Stocks That Are Beating the Market
Feb 21 / GuruFocus News - Paid Partner Content
 

Today’s Trading

Previous close63.07
Today’s open63.14
Day’s range61.50 - 63.22
Volume805,273
Average volume (3 months)1,217,703
Market cap$9.0B
Dividend yield--
Data as of 4:00pm ET, 02/24/2017

Growth & Valuation

Earnings growth (last year)-7.53%
Earnings growth (this year)-72.60%
Earnings growth (next 5 years)-28.70%
Revenue growth (last year)+24.15%
P/E ratioNM
Price/Sales17.76
Price/Book--

Competitors

 Today’s
change
Today’s
% change
JAZZJazz Pharmaceuticals...+0.71+0.52%
TSROTESARO Inc+0.96+0.52%
ALKSAlkermes Plc+0.41+0.78%
RDYDr.Reddy's Laborator...-0.20-0.46%
Data as of 4:02pm ET, 02/24/2017

Financials

Next reporting dateMay 9, 2017
EPS forecast (this quarter)-$0.42
Annual revenue (last year)$418.1M
Annual profit (last year)-$140.1M
Net profit margin-33.51%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Clay B. Siegall
Chief Operating Officer
Eric L. Dobmeier
Corporate headquarters
Bothell, Washington

Forecasts


Search for Jobs